WebFeb 28, 2011 · The telatinib Phase 3 multi-center, double-blind, randomized trial will compare telatinib in combination with a standard regimen of chemotherapy versus chemotherapy alone in advanced stomach ... WebTelatinib (15 mg/kg) with doxorubicin (1.8 mg/kg) significantly decreases the growth rate and tumor size of ABCG2 overexpressing tumors in a xenograft nude mouse model. In conclusion, Telatinib has the potential for the research of cancer disease or in combination with other agents. This still needs further research.
Pharmacogenetics of telatinib, a VEGFR-2 and …
WebNov 11, 2008 · Telatinib (BAY 57-9352) is an orally available, small-molecule inhibitor of vascular endothelial growth factor receptors 2 and 3 (VEGFR-2/-3) and platelet-derived growth factor receptor β ... WebTelatinib is a multi-kinase inhibitor that inhibits VEGF receptor 2 (VEGFR2), VEGFR3, PDGFRα, and c-Kit (IC 50 s = 6, 4, 15, and 1 nM, respectively). 1 It also binds to the transmembrane region of the ABCG2 efflux transporter and enhances intracellular accumulation of [3 H]-mitoxantrone in ABCG2-overexpressing cells. 2 Telatinib (15 … buckwheat sugar content
A phase I multiple-dose escalation study to assess the safety ...
WebJul 27, 2009 · Purpose Telatinib (BAY 57-9352) is an orally available tyrosine kinase inhibitor of vascular endothelial growth factor receptor (VEGFR) -2, VEGFR-3, platelet-derived growth factor receptor-β, and c-Kit. This phase I dose escalation study was conducted to evaluate the safety and tolerability of telatinib, with additional … WebMay 1, 2014 · Cytotoxicity of telatinib alone on ABCG2-overexpressing cell lines was analyzed and was found to be nontoxic with IC 50 values of more than 10 μM (data not shown). Subsequently, a concentration range of 0.25, 0.5 and 1 μM, was selected at which the ABCG2 inhibition ability of telatinib was analyzed for further experiments.HEK293 … WebMay 19, 2011 · Telatinib has shown encouraging antitumor activity in a broad clinical trial program as a single agent in colorectal, kidney, stomach and liver cancers. Based on the encouraging efficacy and ... buckwheat supplier